Pharma & Biotech

Coherus BioSciences has secured a significant partnership for its clinical development efforts, aligning with Janssen Research & Development, a Johnson...

Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...

The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory...

AnaptysBio has confirmed its participation in several upcoming investor conferences, where management will detail a major corporate restructuring. The centerpiece...

Pharmaceutical giant Pfizer is navigating a critical strategic shift, moving decisively away from reliance on its declining COVID-19 business and...

The independent journey of Dynavax Technologies on the public markets is drawing to a definitive close. The biopharmaceutical firm is...

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news. The biotechnology firm...

The chapter for CureVac as an independent publicly traded company has officially closed. The biotech firm's shares have been removed...

Biotechnology firm Arcus Biosciences is executing a strategic overhaul of its clinical development portfolio after a significant late-2025 setback in...

Investors are marking their calendars for a pivotal date in late February 2026. National Healthcare is poised to release its...